Addex Therapeutics (ADXN) Balance Sheet: Assets & Liabilities

Addex Therapeutics (ADXN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Addex Therapeutics reported total assets of CHF 6.36M and total liabilities of CHF 1.60M. Shareholders' equity was CHF 4.77M, down 50.7% from CHF 9.68M a year earlier. Total debt stood at CHF 34.69K against CHF 1.64M in cash and short-term investments, a net cash position of CHF 1.61M. That puts debt-to-equity at 0.01, compared with 0.00 a year earlier.

Addex Therapeutics Balance Sheet Analysis

Values in millions CHF

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Addex Therapeutics Ltd (ADXN) - Annual data in millions CHF
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Mar 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Mar 2020	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	1.64	3.34	3.34	3.87	3.87	6.96	20.48	18.70	31.54	41.67	2.59
Short-Term Investments	0.01	0.01	0.01	0.00	0.00	0.00	0.02	0.06	0.01	0.01	0.00
Cash & Short-Term Investments	1.64	3.35	3.35	3.87	3.87	6.96	20.48	18.76	31.55	41.68	2.59
Accounts Receivable	0.02	0.02	0.02	0.15	0.11	0.42	0.16	0.07	0.12	0.27	0.30
Inventory	0.00	0.00	-	0.00	-	0.00	0.00	0.16	-0.01	0.00	0.00
Other Current Assets	0.02	0.18	0.01	0.22	0.22	0.27	1.12	0.50	0.73	0.20	0.16
Total Current Assets	1.68	3.54	3.54	4.23	4.23	7.83	21.94	19.49	32.39	42.15	3.05
Non-Current Assets
Property, Plant & Equipment (Net)	0.03	0.04	0.04	0.35	0.35	0.40	0.54	0.63	0.57	0.01	0.00
Long-Term Investments	3.85	7.09	7.09	0.00	0.05	0.05	0.06	0.00	0.00	0.05	0.01
Other Non-Current Assets	0.51	0.01	0.01	0.05	0.05	0.05	0.06	0.06	0.07	0.00	0.00
Total Non-Current Assets	4.68	7.14	7.14	0.41	0.41	0.45	0.60	0.69	0.64	0.06	0.01
Total Assets	6.36	10.68	10.68	4.64	4.64	8.28	22.54	20.18	33.03	42.21	3.06
Current Liabilities
Accounts Payable	0.60	0.25	0.25	0.98	2.38	1.28	3.85	0.98	2.22	1.15	0.38
Short-Term Debt	0.01	0.01	-	0.27	-	0.29	0.29	0.31	0.37	0.00	0.00
Accrued Liabilities	0.54	-	0.52	-	1.40	1.60	2.06	1.51	-	-	-
Deferred Revenue	0.00	0.00	-	0.23	0.23	0.00	0.00	0.82	1.11	0.21	0.44
Other Current Liabilities	0.59	0.52	-	1.24	-	1.60	1.86	1.34	1.87	0.96	1.08
Total Current Liabilities	1.20	0.80	0.80	2.89	2.89	3.28	4.13	3.62	5.68	2.33	1.48
Non-Current Liabilities
Long-Term Debt	0.03	0.03	0.03	0.07	0.07	0.09	0.19	0.26	0.18	0.00	0.00
Other Non-Current Liabilities	0.37	0.16	0.16	0.44	0.53	0.00	1.28	1.69	1.48	0.64	0.24
Total Non-Current Liabilities	0.40	0.20	0.20	0.60	0.60	0.09	1.48	1.95	1.82	0.64	0.24
Total Liabilities	1.60	1.00	1.00	3.50	3.50	3.37	5.61	5.57	7.50	2.97	1.72
Stockholders' Equity
Common Stock	2.19	1.84	1.84	1.84	1.84	1.15	49.27	32.85	32.85	28.56	13.42
Retained Earnings	-360.09	-353.36	-353.36	-360.42	-360.42	-349.86	-329.06	-313.71	-300.85	-286.07	-284.42
Accumulated Other Comprehensive Income	31.76	31.06	31.06	29.81	29.81	25.77	24.44	14.66	7.15	10.27	7.55
Treasury Stock	1.01	-	0.87	-	0.91	6.28	11.70	-	-	-	-
Additional Paid-in Capital	267.31	330.13	266.38	329.91	266.19	269.51	272.28	280.81	286.38	286.48	264.85
Shares Outstanding	117.93	-	98.34	-	95.24	77.13	37.90	-	-	-	-
Total Stockholders' Equity	4.77	9.68	9.68	1.15	1.15	4.91	16.93	14.61	25.52	39.24	1.34
Total Liabilities & Equity	6.36	10.68	10.68	4.64	4.64	8.28	22.54	20.18	33.03	42.21	3.06

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Addex Therapeutics Balance Sheet

How much debt does Addex Therapeutics have?

Addex Therapeutics had total debt of CHF 34.69K as of Dec 31, 2025, against CHF 1.64M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was CHF 41.99K a year earlier.

What are Addex Therapeutics's total assets?

Addex Therapeutics reported total assets of CHF 6.36M as of Dec 31, 2025, down 40.4% from CHF 10.68M a year earlier. Total liabilities were CHF 1.60M.

What is Addex Therapeutics's shareholders' equity?

Addex Therapeutics's shareholders' equity was CHF 4.77M as of Dec 31, 2025, or about CHF 0.04 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition